It really depends on who the shares were sold to during the...

It really depends on who the shares were sold to during the capital raise and whether their intention is to drive the SP lower since you might get in at an even lower price than $3.62. Anywhere in the low $3 range is a bargain, but depending on world events i.e. interest rate hikes, recession fears, russia etc the price might even go into the low $2 range. I sold out in early January since it will take some time for TLX to generate substantial revenues.

You can read the following article to get an idea of the challenges that await TLX:
https://www.fiercepharma.com/marketing/oncologists-very-likely-to-prescribe-novartis-prostate-cancer-radiotherapy-but-worry

TLX has a lot of cash, a good pipeline and a product that will generate good revenues once it can overcome the logistical challenges it is expected to face, but this will take around 3 years IMO. My expected outlook for TLX is very positive and I will look to get back in at a good price.